Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19372485rdf:typepubmed:Citationlld:pubmed
pubmed-article:19372485lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:19372485lifeskim:mentionsumls-concept:C0031268lld:lifeskim
pubmed-article:19372485lifeskim:mentionsumls-concept:C0058698lld:lifeskim
pubmed-article:19372485lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:19372485lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:19372485lifeskim:mentionsumls-concept:C0032743lld:lifeskim
pubmed-article:19372485lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:19372485lifeskim:mentionsumls-concept:C0392762lld:lifeskim
pubmed-article:19372485lifeskim:mentionsumls-concept:C0599278lld:lifeskim
pubmed-article:19372485pubmed:issue5lld:pubmed
pubmed-article:19372485pubmed:dateCreated2009-4-30lld:pubmed
pubmed-article:19372485pubmed:abstractTextIt has been demonstrated in vitro that the dopamine D(2) receptor has 2 interconvertible affinity states for endogenous dopamine, referred to as the high- and the low-affinity states. (11)C-(R)-2-CH(3)O-N-n-propylnorapomorphine ((11)C-MNPA) is a new agonist radioligand for in vivo imaging of the high-affinity state of dopamine D(2) receptors using PET. In the present study, the kinetics of (11)C-MNPA were examined for the first time, to our knowledge, in the human brain and analyzed using quantitative approaches with or without an arterial input function.lld:pubmed
pubmed-article:19372485pubmed:languageenglld:pubmed
pubmed-article:19372485pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372485pubmed:citationSubsetIMlld:pubmed
pubmed-article:19372485pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372485pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372485pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372485pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372485pubmed:statusMEDLINElld:pubmed
pubmed-article:19372485pubmed:monthMaylld:pubmed
pubmed-article:19372485pubmed:issn0161-5505lld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:SuzukiKazutos...lld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:SuharaTetsuya...lld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:HalldinChrist...lld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:FardeLarsLlld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:ItoHiroshiHlld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:HirayasuYoshi...lld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:TakanoHarumas...lld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:SekiChieClld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:TakahashiHide...lld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:KodakaFumitos...lld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:FinnemaSjoerd...lld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:OkumuraMasaki...lld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:NakaoRyujiRlld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:ArakawaRyosuk...lld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:OtsukaTatsuiTlld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:MiyoshiMichie...lld:pubmed
pubmed-article:19372485pubmed:authorpubmed-author:SekineMizuhoMlld:pubmed
pubmed-article:19372485pubmed:issnTypePrintlld:pubmed
pubmed-article:19372485pubmed:volume50lld:pubmed
pubmed-article:19372485pubmed:ownerNLMlld:pubmed
pubmed-article:19372485pubmed:authorsCompleteYlld:pubmed
pubmed-article:19372485pubmed:pagination703-10lld:pubmed
pubmed-article:19372485pubmed:meshHeadingpubmed-meshheading:19372485...lld:pubmed
pubmed-article:19372485pubmed:meshHeadingpubmed-meshheading:19372485...lld:pubmed
pubmed-article:19372485pubmed:meshHeadingpubmed-meshheading:19372485...lld:pubmed
pubmed-article:19372485pubmed:meshHeadingpubmed-meshheading:19372485...lld:pubmed
pubmed-article:19372485pubmed:meshHeadingpubmed-meshheading:19372485...lld:pubmed
pubmed-article:19372485pubmed:meshHeadingpubmed-meshheading:19372485...lld:pubmed
pubmed-article:19372485pubmed:meshHeadingpubmed-meshheading:19372485...lld:pubmed
pubmed-article:19372485pubmed:meshHeadingpubmed-meshheading:19372485...lld:pubmed
pubmed-article:19372485pubmed:meshHeadingpubmed-meshheading:19372485...lld:pubmed
pubmed-article:19372485pubmed:meshHeadingpubmed-meshheading:19372485...lld:pubmed
pubmed-article:19372485pubmed:meshHeadingpubmed-meshheading:19372485...lld:pubmed
pubmed-article:19372485pubmed:meshHeadingpubmed-meshheading:19372485...lld:pubmed
pubmed-article:19372485pubmed:year2009lld:pubmed
pubmed-article:19372485pubmed:articleTitleQuantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain.lld:pubmed
pubmed-article:19372485pubmed:affiliationMolecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan.lld:pubmed
pubmed-article:19372485pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19372485pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:1813entrezgene:pubmedpubmed-article:19372485lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19372485lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19372485lld:pubmed